Emyria Limited (ASX:EMD)
0.0610
-0.0040 (-6.15%)
Nov 5, 2025, 4:10 PM AEST
Emyria Market Cap
Emyria has a market cap or net worth of 43.29 million as of November 4, 2025. Its market cap has increased by 272.17% in one year.
Market Cap
43.29M
Enterprise Value
40.33M
Revenue
1.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since February 12, 2020, Emyria's market cap has increased from 26.67M to 43.29M, an increase of 62.33%. That is a compound annual growth rate of 8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 43.29M | 176.42% |
| Dec 30, 2024 | 15.66M | -17.86% |
| Dec 29, 2023 | 19.06M | -61.44% |
| Dec 30, 2022 | 49.44M | -53.29% |
| Dec 31, 2021 | 105.86M | 410.23% |
| Dec 31, 2020 | 20.75M | -22.19% |
| Feb 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.54B |
| Pro Medicus | 27.34B |
| Cochlear | 18.36B |
| Sonic Healthcare | 10.34B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.35B |
| Ansell | 5.20B |
| Mesoblast | 3.18B |